AHA GUIDELINES Bundle (free trial)

Diagnosis and Management of Aortic Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1483260

Contents of this Issue

Navigation

Page 51 of 97

52 Treatment 6.5.3.3. Left Subclavian Artery Management COR LOE Recommendations 1 B-NR 1. In patients with descending TAA who undergo TEVAR with planned left subclavian artery coverage, revascularization of the left subclavian artery before TEVAR is recommended to prevent spinal cord injury (SCI) and potentially to reduce stroke risk and prevent other ischemic complications. 2b C-LD 2. In patients with descending TAA who have undergone TEVAR with left subclavian coverage and develop SCI that is unresponsive to an increase in BP or a cerebrospinal fluid drain, left subclavian artery revascularization may be considered. 6.5.3.4. Celiac Artery Management COR LOE Recommendation 2a B-NR 1. In patients with descending TAA undergoing TEVAR in whom celiac artery coverage is being considered, it is reasonable to first confirm adequate collateralization. 6.5.3.5. Ruptured Descending TAA COR LOE Recommendations 1 B-NR 1. In patients with ruptured descending TAA who are anatomic candidates for endovascular repair, TEVAR is recommended over open repair because of decreased perioperative death and morbidity. 2b B-NR 2. In patients with ruptured descending TAA undergoing TEVAR, intentional coverage of the left subclavian artery, celiac artery, or both may be considered to increase the landing zone for endovascular repair.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Diagnosis and Management of Aortic Disease